483 Roundup: Six Firms Flagged for Variety of Violations
The FDA issued Form 483 reports to facilities in Germany, China, Mexico, South Korea, the United Kingdom and the U.S. for a range of nonconformance issues.
Source: Drug GMP Report
The FDA issued Form 483 reports to facilities in Germany, China, Mexico, South Korea, the United Kingdom and the U.S. for a range of nonconformance issues.
Source: Drug GMP Report